Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) EBIT: 2009-2011

Historic EBIT for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$114.1 million.

  • Lexicon Pharmaceuticals' EBIT fell 48.68% to -$33.3 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$114.1 million, marking a year-over-year decrease of 19.20%. This contributed to the annual value of -$114.1 million for FY2011, which is 19.20% down from last year.
  • As of FY2011, Lexicon Pharmaceuticals' EBIT stood at -$114.1 million, which was down 19.20% from -$95.7 million recorded in FY2010.
  • Lexicon Pharmaceuticals' 5-year EBIT high stood at -$90.0 million for FY2009, and its period low was -$114.1 million during FY2011.
  • In the last 3 years, Lexicon Pharmaceuticals' EBIT had a median value of -$95.7 million in 2010 and averaged -$99.9 million.
  • Data for Lexicon Pharmaceuticals' EBIT shows a maximum YoY declined of 19.20% (in 2011) over the last 5 years.
  • Over the past 3 years, Lexicon Pharmaceuticals' EBIT (Yearly) stood at -$90.0 million in 2009, then fell by 6.41% to -$95.7 million in 2010, then decreased by 19.20% to -$114.1 million in 2011.